An IL-2-grafted antibody immunotherapy with potent efficacy against metastatic cancer
IL-2/anti-IL-2 complexes have been proposed to curtail the severe adverse effects associated with IL-2 immunotherapy. Here, the authors, by integrating unmutated human IL-2 in the antigen binding groove of an anti-IL-2 monoclonal antibody, generate a CD122-biased fusion protein that prevents binding...
Enregistré dans:
Auteurs principaux: | Dilara Sahin, Natalia Arenas-Ramirez, Matthias Rath, Ufuk Karakus, Monika Hümbelin, Merel van Gogh, Lubor Borsig, Onur Boyman |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/bccae141645e49d6828a1fe5efe66a25 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
TGFβ Signaling in Myeloid Cells Promotes Lung and Liver Metastasis Through Different Mechanisms
par: Cristina Stefanescu, et autres
Publié: (2021) -
Nanotechnology-enhanced immunotherapy for metastatic cancer
par: Peisen Zhang, et autres
Publié: (2021) -
Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy
par: Hong-fen Guo, et autres
Publié: (2021) -
Improving cancer immunotherapy by targeting IL-1
par: Zhilan Xiao, et autres
Publié: (2021) -
Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder Cancer
par: David J. Benjamin, et autres
Publié: (2021)